# FDA Inspection 965008 - AstraZeneca Pharmaceuticals LP - February 26, 2016

Source: https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/089e55b9-257b-4cc4-8617-b5ce1917f26d
Source feed: FDA_Inspections

> FDA Inspection 965008 for AstraZeneca Pharmaceuticals LP on February 26, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 965008
- Company Name: AstraZeneca Pharmaceuticals LP
- Inspection Date: 2016-02-26
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1155949 - 2021-10-25](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f2c5e809-e869-402f-9489-237132483c53)

Company: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/cdab8252-da58-4421-a8f1-1396e3aff309

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c